Dispatch Biotherapeutics
Immunotherapy for Solid Tumors
Philadelphia, United States · Founded 2022 · $106.0M raised
- Headquarters
- Philadelphia
- Founded
- 2022
- Business Model
- B2B
- Website
- dispatchbio.com
- Total Funding
- $106.0M
- Last Round
- $100.0M Series AJul 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Dispatch Biotherapeutics (Dispatch Bio) is a clinical-stage immunotherapy company founded in 2022 with a bold purpose: to help create a world where all cancer patients can be cured. The company is engineering a universal treatment across solid tumors through its first-in-class Flare platform, which combines the precision of immunotherapy with a tumor-specific virus engineered to clear tumor cells. Co-founded by scientists from Stanford, UCSF, Penn, and Memorial Sloan Kettering, Dispatch operates R&D sites in Philadelphia and San Francisco and is backed by ARCH Venture Partners.
Summary
Dispatch Biotherapeutics is a Biotech company based in Philadelphia, United States, founded in 2022. It has raised $106.0M in total across 2 rounds, most recently a $100.0M Series A round in Jul 2025. Investors include Parker Institute for Cancer Immunotherapy, ARCH Venture Partners and Bristol Myers Squibb.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jul 2025
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/dispatch-biotherapeutics"><img src="https://indexed.vc/api/badge/company/dispatch-biotherapeutics" alt="Dispatch Biotherapeutics on Indexed.vc" width="260" height="76" /></a>